Gelonghui September 6?Qizheng Tibetan Medicine (002287.SZ) held a performance presentation meeting on September 6, 2023, on "collection has a great potential impact on paste, how will the company deal with it?" The company replied that no products have been included in the collection at present. The company continues to pay attention to the relevant national policy release and implementation rules, from the management and products and other aspects to enhance the competitiveness of the enterprise brand. Fine management, strengthen organizational construction, gradually promote the provincial and regional line management system, activate organizational vitality, and establish a professional and independent academic promotion team. Channel sinking, layout and development of county-level hospitals and grass-roots medical market, optimize the matching of various channel resources. Professional drive, compliance management, academic guidance, increase investment in product basic research, clinical value, high-level evidence-based medicine research, improve each product evidence chain, enhance product clinical value and product competitiveness, and promote sustainable business development. Through brand marketing, strengthen the promotion of merchant zero channels. At the same time, the company continues to enrich the product line, through the allocation of resources to develop Bai Mai Ointment, Qingpeng Ointment, Safflower Ruyi pills and other products. The proportion of Xiaotong paste in the company's overall sales revenue is decreasing year by year.